Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

134 results about "Cardiac output" patented technology

Cardiac output, also denoted by the symbols Q, or Qc, is a term used in cardiac physiology that describes the volume of blood being pumped by the heart, in particular by the left or right ventricle, per unit time. Cardiac output is the product of the heart rate (HR), or the number of heart beats per minute (bpm), and the stroke volume (SV), which is the volume of blood pumped from the ventricle per beat; thus, CO = HR × SV.

Systems and methods for determining cardiac performance

The systems and methods described herein determine metrics of cardiac performance via a mechanical circulatory support device and use the cardiac performance to calibrate, control and deliver mechanical circulatory support for the heart. The systems include a controller configured to operate the device, receive inputs indicative of device operating conditions and hemodynamic parameters, and determine vascular performance, including vascular resistance and compliance, and native cardiac output. The systems and methods operate by using the mechanical circulatory support device (e.g., a heart pump) to introduce controlled perturbations of the vascular system and, in response, determine heart parameters such as stroke volume, vascular resistance and compliance, left ventricular end diastolic pressure, and ultimately determine native cardiac output.
Owner:ABIOMED INC +2

Multi-modal heart and cerebral hemodynamics monitoring method and device

The invention relates to a multi-mode heart and cerebral hemodynamics monitoring method and device, and belongs to the technical field of medical equipment. According to the method, brain absorbance information and pulse wave information at the middle artery of the brain are obtained based on a near infrared spectrum technology by utilizing the relevance among the cardiac output, blood pressure, intracranial pressure and cerebral perfusion pressure of a human body, cardiac output information and cuff-free blood pressure information are obtained based on a thoracic impedance method, and physiological signals are obtained based on the two methods; and carrying out fusion processing to obtain a multi-modal signal, and further constructing a non-invasive monitoring model of non-invasive intracranial pressure, cardiac output, blood pressure and cerebral perfusion pressure, so as to realize continuous non-invasive monitoring reflecting human heart and cerebral hemodynamic parameters. According to the invention, through fusion application of multi-mode signals, the mechanism of cardio-cerebral hemodynamics interaction can be effectively disclosed, and a more effective, safer and noninvasive monitoring means is provided for clinic.
Owner:CHONGQING UNIV

Systems for delivering implantable devices across an atrial septum

PendingUS20250195853A1StentsHeart valvesLeft ventricular sizeLeft atrial pressure
Systems and methods for delivering a device for regulating blood pressure across a patient's atrial septum are provided. The delivery apparatus may include a first catheter, a hub having one or more engagers disposed thereon, the one or more engagers configured to releasably engage with a first expandable end of the shunt in a contracted delivery state within a lumen of a sheath, and an second catheter extending through a center lumen of the first catheter and the hub, wherein the first catheter, the hub, and the second catheter are independently moveable relative to the sheath. The inventive devices may reduce left atrial pressure and left ventricular end diastolic pressure, increase cardiac output, increase ejection fraction, relieve pulmonary congestion, and lower pulmonary artery pressure, among other benefits. The inventive devices also may be used to treat subjects having heart failure, pulmonary congestion, or myocardial infarction, among other pathologies.
Owner:WAVE LTD V

Method and device for training percutaneous ventricular assist device control model

PendingCN120562305AControl devicesBlood pumpsDecision controlAorta blood pressure
The invention discloses a method and device for training a percutaneous ventricular assist device control model, and the method comprises the steps: obtaining a multi-mode real-time physiological signal of the cardiovascular state of a monitored user through simulation of a simulation platform; real-time physiological signals are used as input data to be input into the deep reinforcement learning model for training, and a control model of the percutaneous ventricular assist device capable of achieving pump speed real-time decision control is obtained; the control model is trained according to the real-time input data, so that the adaptivity of the control model is improved; performing reinforcement learning training of the control model through a reward function comprising the first reward sub-function item and the second reward sub-function item; after the percutaneous ventricular assist device is loaded with the obtained control model, the percutaneous ventricular assist device has the capability of recovering dynamic characteristics and pulsation characteristics of cardiac output and aortic pressure of a user, so that the cardiac output and the aortic pressure of a heart failure user are close to a normal physiological state, and the control model provides a basis for improving the operation quality of the percutaneous ventricular assist device; and technical guarantee is provided for cardiovascular health of the user.
Owner:TSINGHUA UNIVERSITY

Device for non-invasively calculating cardiac output and operating method therefor

PCT designated stage expiredWO2024257970A1Medical data miningHealth-index calculationPhotoplethysmogramStroke index
The present invention relates to a device for non-invasively calculating a cardiac output and an operation method therefor. The method comprises the steps of: receiving first bio-signal data including an electrocardiogram and a photoplethysmogram of a user; and determining a stroke volume of the user on the basis of the first bio-signal data of the user by using a deep learning model configured to output the stroke volume, with the electrocardiogram and the photoplethysmogram used as inputs.
Owner:SEOUL NAT UNIV HOSPITAL

Physical sign data processing system

The invention discloses a physical sign data processing system, and relates to the technical field of cardiology department medical information, a data acquisition module is used for acquiring physiological data of heart rate, blood pressure and cardiac output of a patient in real time, and a data analysis processing module is used for substituting, calculating and outputting to obtain a heart rate variability index XB; the heart rate variability index XB, the heart workload evaluation index XFZ and the dynamic heart efficiency index DXL are acquired, statistical analysis and trend prediction are performed based on the result value of the dynamic heart efficiency index DXL, and encrypted storage and secure backup are performed on the acquired physiological data, the heart rate variability index XB, the heart workload evaluation index XFZ and the dynamic heart efficiency index DXL. According to the heart health assessment system, a more comprehensive, accurate and scientific heart health assessment tool is provided for doctors through the beneficial effects and optimization innovation of enhancing data security, optimizing a data processing algorithm and constructing a comprehensive assessment index.
Owner:SHAANXI NUOXING YOUCHUANG INFORMATION TECHNOLOGY CO LTD

Balloon type left ventricle auxiliary device for preventing thrombus generation

The balloon type left ventricle auxiliary device comprises an outer cup-shaped element, an inner balloon, a catheter assembly, a baffle valve, a far-end connecting piece, a connector, a Y-shaped connector and a traction wire, and the outer cup-shaped element is provided with a plurality of inflow holes and an outflow opening; the inner balloon is arranged on the inner side of the outer cup-shaped element and is communicated with the catheter assembly; the baffle valve is arranged between the outer cup-shaped element and the inner balloon and serves as a one-way valve to control blood to flow into the inner cavity in a one-way mode. The far-end connecting piece is provided with a backflow hole, and thrombus generation can be prevented; the Y-shaped connector is connected with the joint; the far end of the traction wire is connected with the elastic support of the external cup-shaped element, extends out of the body through the catheter inner cavity, the connector and the Y-shaped connector and is used for assisting the device in being recycled to the sheathing canal. According to the device, blood is pumped into the ascending aorta from the left ventricle through periodic contraction and expansion of the internal balloon and periodic change of the internal volume in combination with the inflow hole, the outflow hole and the baffle valve, and the cardiac output is increased.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Balloon counterpulsation device in double-balloon aorta

InactiveCN119524308Aincrease resistancereduce loadBlood pumpsIntra-aortic balloon counterpulsationMedical equipment
The invention discloses a double-balloon in-aorta balloon counterpulsation device, and relates to the technical field of medical equipment. The balloon catheter comprises a control host, a catheter shaft, a main balloon and an auxiliary balloon, the catheter shaft is arranged on the control host, and the main balloon and the auxiliary balloon are arranged at the other end of the catheter shaft; the main balloon is a long-strip-shaped hollow air bag, the auxiliary balloon is any one of a cylindrical hollow air bag, a conical hollow air bag and a hemispherical hollow air bag, and an inner cavity of the main balloon is larger than an inner cavity of the auxiliary balloon. A guide wire channel is arranged in the catheter shaft and penetrates through the auxiliary balloon and the main balloon; by arranging the main balloon and the auxiliary balloon, when the left ventricle begins to contract and the aortic valve is opened, the main balloon begins to contract, and meanwhile, the auxiliary balloon delays to start to contract, so that the suction resistance to the telecentric end when the main balloon contracts is increased, the reverse blood flow extracted from the telecentric end is reduced, the suction effect on the proximal end is improved, and the cardiac output is increased.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Left ventricular volume and cardiac output estimation using machine learning model

Methods and systems are disclosed for creating and using a neural network model to estimate a cardiac parameter of a patient, and using the estimated parameter in providing blood pump support to improve patient cardiac performance and heart health. Particular adaptations include adjusting blood pump parameters and determining whether and how to increase or decrease support, or wean the patient from the blood pump altogether. The model is created based on neural network processing of data from a first patient set and includes measured hemodynamic and pump parameters compared to a cardiac parameter measured in situ, for example the left ventricular volume measured by millar (in animals) or inca (in human) catheter. After development of a model based on the first set of patients, the model is applied to a patient in a second set to estimate the cardiac parameter without use of an additional catheter or direct measurement.
Owner:ABIOMED INC

Interatrial shunts having biodegradable material, and methods of making and using same

ActiveUS12465485B2StentsHeart valvesLeft ventricular sizeLeft atrial pressure
A device for regulating blood pressure between a patient's left atrium and right atrium comprises an hourglass-shaped stent comprising a neck region and first and second flared end regions, the neck region disposed between the first and second end regions and configured to engage the fossa ovalis of the patient's atrial septum, and a drug-eluting biodegradable material that biodegrades over time to release a drug that limits tissue overgrowth. The inventive device also may include a biodegradable material that biodegrades to offset flow changes caused by tissue overgrowth. The inventive device may reduce left atrial pressure and left ventricular end diastolic pressure, and may increase cardiac output, increase ejection fraction, relieve pulmonary congestion, and lower pulmonary artery pressure, among other benefits.
Owner:WAVE LTD V

Apparatus and methods for optimizing intra cardiac filling pressures, heart rate, and cardiac output

Apparatus, systems, and methods are provided for optimizing intracardiac filling pressures and cardiac output in patients with heart failure, conduction disease, and atrial fibrillation. The system is able to adjust and optimize intracardiac filling pressures and cardiac output by adjusting heart rate and the effective amount of total body blood volume. The device includes an adjustable member that may create a mean pressure differential in order to manifest an effective “mechanical diuresis” by sequestering extraneous blood volume to the high-capacitance of the venous vasculature. The system is therefore designed to reduce intracardiac filling pressures while maintaining or even increasing cardiac output.
Owner:CARDIOFLOW TECH

Devices for reducing left atrial pressure, and methods of making and using same

ActiveUS12502272B2Heart valvesSurgeryLeft ventricular sizeLeft atrial pressure
A device for regulating blood pressure between a patient's left atrium and right atrium comprises an hourglass-shaped stent comprising a neck region and first and second flared end regions, the neck region disposed between the first and second end regions and configured to engage the fossa ovalis of the patient's atrial septum; and a one-way tissue valve coupled to the first flared end region and configured to shunt blood from the left atrium to the right atrium when blood pressure in the left atrium exceeds blood pressure in the right atrium. The inventive devices may reduce left atrial pressure and left ventricular end diastolic pressure, and may increase cardiac output, increase ejection fraction, relieve pulmonary congestion, and lower pulmonary artery pressure, among other benefits. The inventive devices may be used, for example, to treat subjects having heart failure, pulmonary congestion, or myocardial infarction, among other pathologies.
Owner:WAVE LTD V

Systems and methods for determining filtered cardiac output

A system for determining placement of a catheter in a patient includes a hemodynamic sensor and a display. The hemodynamic sensor produces a signal representative of a right ventricular pressure waveform of the patient. The catheter is connected to the hemodynamic sensor. The system further includes one or more processors and computer-readable memory encoded with instructions that, when executed by the one or more processors, cause the system to receive the signal representative of the right ventricular pressure waveform and extract features from the right ventricular pressure waveform. The instructions further cause the system to compare the features to one or more value ranges of the features to determine that the catheter is correctly placed when values of the features are within the one or more value ranges or that the catheter is incorrectly placed, is not properly connected to the system, or signal quality issues are occurring.
Owner:BECTON DICKINSON & CO

Adaptive control method and equipment based on external counterpulsation device and medium

The invention discloses a self-adaptive control method and equipment based on an external counterpulsation device and a medium, and relates to the technical field of hemodynamics, and the method comprises the following steps: obtaining the gas inflation and deflation speed of the external counterpulsation device, carrying out air bag volume accumulation analysis on the gas inflation and deflation speed, and determining air bag volume data; based on the air bag volume data, through air bag pressure change analysis, blood vessel pressure data generated by the air bag on the limb is obtained; according to the blood vessel pressure data, the blood inflow amount of the left atrium is determined through blood backflow state analysis in the diastolic period; performing left ventricular ejection stroke-per-volume analysis on the left atrium blood inflow in a systolic period to obtain cardiac output data; based on cardiac output data or gas inflation and deflation speed, a self-adaptive regulation and control strategy of the in-vitro counterpulsation device is determined through real-time analysis of hemodynamic parameters. By means of the method, the problem that in the prior art, the external counterpulsation device cannot be adjusted in real time according to the current state of the user is solved.
Owner:MIRACLINK MEDICAL TECH (SHENZHEN) CO LTD

Method and apparatus for intrachamber resynchronization

InactiveUS12642973B2Heart stimulatorsBlood flowCongestive heart failure chf
Methods, apparatus, and systems are provided to control contraction of the heart. At least one sensing element receives signals indicating electrical activity of sinus rhythm of the heart. Based on the received signals, the progress of contraction of the heart is determined. Based on the progress of contraction, the chamber of the heart may then be stimulated at a plurality of locations. In another embodiment, a plurality of electrodes are implanted in the left ventricle to stimulate at multiple locations in the left ventricle for the purpose of improving hemodynamic performance and increasing cardiac output in a patient who is suffering from congestive heart failure.
Owner:MIROWSKI FAMILY VENTURES LLC

Apparatus for non-invasively computing cardio-vasculature parameters using morphology of uncalibrated pressure wave signal

PendingUS20260182930A1Sensor arrayAorta part
Systems and apparatus are provided for using a non-invasively monitored uncalibrated pressure signal from a patient to compute cardiac output and other cardio-vascular parameters, thereby providing safe, effective, reliable and low cost monitoring of patient health. Wearable devices are disclosed that include a sensor array for obtaining patient data that is used to provide an estimate of aortic systolic blood pressure, cardiac output, and end-systolic elastance that may be determined without the need for a cuff.
Owner:ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)

Non-invasive vital sign monitoring system and method

The invention relates to the technical field of vital sign monitoring, and discloses a non-invasive vital sign monitoring system and method.The system comprises a basic vital sign monitoring module, an extended vital sign monitoring module, a hemodynamic monitoring module and a monitoring and early warning module; the basic vital sign monitoring module is used for monitoring breathing related indexes and stress indexes; an oxyhemoglobin saturation monitoring unit of the extended vital sign monitoring module is used for acquiring a PPG signal through a photoelectric volume sensor and monitoring oxyhemoglobin saturation according to the PPG signal; the hemodynamics monitoring module is used for carrying out cuff-free blood pressure monitoring on the basis of pulse transmission time delay and monitoring output quantity per stroke and cardiac output quantity according to the electrocardiogram signal, the PPG signal and the pulse transmission time delay; and the monitoring and early warning module is used for determining the comprehensive health index of the patient according to the monitoring data of the basic vital sign monitoring module, the extended vital sign monitoring module and the hemodynamics monitoring module, and carrying out prediction and early warning on the physiological state of the patient.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV +1

Ai based computing system and method for prediciting continuous cardiac output (CCO) of patients

A system and method for predicting the Continuous Cardiac Output (CCO) of patients is disclosed. The method includes receiving a request from one or more patients and one or medical professionals and determining a set of recovery patterns of the one or more patients. The method further classifying the one or more patients into one or more predefined profiles and predicting the CCO of the one or more patients based on the request, the set of recovery patterns and result of classification using health management based AI model. Further, the method includes generating recommendations corresponding to the predicted CCO and outputting the predicted CCO of the one or more patients and the generated recommendations along with insights on user interface screen of electronic devices associated with the one or more patients and the one or more medical professionals, to take corrective actions in real time and future.
Owner:IQGATEWAY LLC

Percutaneous circulation auxiliary device

The utility model discloses a percutaneous circulation auxiliary device. The percutaneous circulation auxiliary device comprises an intervention catheter and a diaphragm pump. The intervention catheter is provided with at least one blood inlet and at least one blood outlet, the blood inlet and the blood outlet are both one-way valves and are both in one-way conduction, and the diaphragm pump comprises a blood cavity separated by a flexible diaphragm and a driving liquid cavity used for charging and discharging liquid. When in use, the device is communicated with a liquid charging and discharging control device, is mainly used for assisting blood pumping of the right ventricle, can be placed into the right ventricle through femoral veins, assists the heart in doing work, and increases cardiac output; the utility model relates to a pulsating pump which can pump blood according to systole and diastole of the heart. The device is simple in structure and low in manufacturing cost, and has a good application prospect.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV +1

Apparatus and methods for optimizing intra cardiac filling pressures, heart rate, and cardiac output

PCT designated stage expiredWO2025019838A1Dialysis systemsControl devicesVeinNormal blood volume
Apparatus, systems, and methods are provided for optimizing intracardiac filling pressures and cardiac output in patients with heart failure, conduction disease, and atrial fibrillation. The system is able to adjust and optimize intracardiac filling pressures and cardiac output by adjusting heart rate and the effective amount of total body blood volume. The device includes an adjustable member that may create a mean pressure differential in order to manifest an effective "mechanical diuresis" by sequestering extraneous blood volume to the high-capacitance of the venous vasculature. The system is therefore designed to reduce intracardiac filling pressures while maintaining or even increasing cardiac output.
Owner:ABLATION INNOVATIONS LLC +2

Systems and methods to predict global hypoperfusion in critical care patients

A system for determining a global hypoperfusion index (GHI) includes an arterial blood pressure sensor, a ventricular blood pressure sensor, an oximetry module, and an integrated hardware unit including a system processor and a system memory. The system memory includes instructions that cause the system to receive arterial hemodynamic data, ventricular hemodynamic data, and blood oxygen saturation data. One or more right ventricular pressure features, one or more pulmonary artery pressure features, one or more cardiac output parameters, and one or more venous oxygen saturation parameters are derived from the arterial hemodynamic data, the ventricular hemodynamic data, and the blood oxygen saturation data. The GHI is derived by using a predictive decision model based upon the one or more right ventricular pressure features, the one or more pulmonary artery features, the one or more cardiac output parameters, and the one or more venous oxygen saturation parameters.
Owner:BECTON DICKINSON & CO

Application of Macrolide Derivatives in the Preparation of Drugs for Treating Heart Failure

The present invention relates to the field of pharmaceutical technology, and specifically to the application of a macrolide derivative in the preparation of a drug for treating heart failure. The present invention provides a new use of a macrolide derivative. Experimental results show that this macrolide derivative significantly improves the cardiac function of heart failure mice, increases the ejection fraction (EF%), fractional shortening (FS%), and cardiac output per minute (CO), without changing the heart rate (HR), is equivalent to the positive drug digoxin, and is superior to enalapril; at the same time, it has the effects of reducing the heart weight ratio, improving myocardial hypertrophy and fibrosis, and has good clinical prospects and social benefits.
Owner:GUANGXI ZHONGHENG INNOVATIVE PHARM RES CO LTD

Intraoperative brain oxygen saturation image dynamic monitoring and early warning system and method for elderly patients

PendingCN122440138ABlood flowDynamic monitoring
The present application relates to the technical field of medical image monitoring, in particular to an intraoperative cerebral oxygen saturation image dynamic monitoring and early warning system and method for elderly patients, comprising a bilateral cerebral oxygen acquisition module, a cerebral oxygen waveform image construction module, a cerebral oxygen image feature extraction module, a hierarchical early warning module and a multi-parameter linkage display module, through the bilateral cerebral oxygen saturation time series signals output by the bilateral near-infrared cerebral oxygen saturation sensors are synthesized into a double-channel cerebral oxygen waveform image aligned with the same time window start and end time and sharing the amplitude scale, three types of geometric morphological features of bilateral cerebral oxygen slope, bilateral cerebral oxygen asymmetry index and relative baseline drop amplitude are uniformly extracted in the image domain, three types of high-risk mode hierarchical triggering of unilateral cerebral oxygen threshold persistence, relative baseline drop and bilateral asymmetry are driven, and the invasive arterial pressure, cardiac output, anesthesia depth index waveform and hemodynamic event characteristic root cause pairing display are jointly presented.
Owner:DALIAN FRIENDSHIP HOSPITAL

Method for processing arterial blood pressure waveform signal through residual neural network

The invention relates to the technical field of vital sign detection, in particular to a method for processing an arterial blood pressure waveform signal through a residual neural network. Comprising the following steps: preprocessing an arterial blood pressure waveform signal and extracting a characteristic value; performing short-time Fourier transform on the arterial blood pressure waveform signals to generate amplitude and phase images of the signals in a time-frequency domain, and inputting the images and characteristic values into a residual neural network model to obtain predicted values of hemodynamic parameters including cardiac output and stroke output; and predicting the blood pressure trend in a certain time in the future by using the time sequence prediction capability of the residual neural network. According to the method, more accurate heart and displacement parameter prediction and more accurate hypotension event prediction are provided; in addition, uncertainty quantization of hypotension event prediction is also increased.
Owner:ZHEJIANG HAISHENG MEDICAL DEVICE CO LTD

A non-invasive continuous real-time blood pressure and hemodynamics and ECG and heart sound heart function integrated device and data calculation method thereof

ActiveCN115462769BBlood pressure output data is accurateSolving blood pressureStethoscopeEvaluation of blood vesselsInvasive hemodynamicsBlood flow
The application discloses a non-invasive continuous real-time blood pressure and hemodynamics and heart function integrated device and a data calculation method thereof, which comprises a signal acquisition module, a statistical and weighted calculation module, a communication module and a display module which are electrically connected with a main control board, wherein the signal acquisition module comprises an ECG and heart sound digitization detection module and a real-time continuous blood pressure and hemodynamics calculation module.The application has the beneficial effects that: the device combines the heart sound and ECG with the non-invasive hemodynamics acquisition device, and the blood pressure parameters obtained by the device are mutually calibrated, so that the device not only solves the problems of real-time continuous blood pressure and hemodynamics detection, but also synchronously outputs ECG parameters, heart sound logarithms, cardiac output, stroke volume, vascular resistance, cardiac contractility and other parameters.
Owner:ZHEJIANG SHANSHI BIOLOGICAL MEDICAL DEVICES (SHANGQIU) CO LTD

Device, system and method for monitoring of peripheral arterial perfusion of a subject

ActiveUS12543959B2CatheterOptical sensorsBlood flowCardiac low output
The present invention relates to a device, system and method for monitoring of peripheral arterial perfusion of a subject. To enable distinguishing between low pulsatility caused by centralization or low cardiac output, the proposed device comprises an input (30) for receiving first detection data of a tissue region of a subject, said first detection data being acquired over time by detecting radiation reflected from and / or transmitted through tissue of the subject, and for receiving second detection data of a skin region of subject, said second detection data being acquired over time by detecting radiation received from said tissue region in response to coherent light being emitted towards said skin region, a PPG unit (32) for deriving a photoplethysmography, PPG, signal from said first detection data, a flow unit (34) for deriving, from said second detection data, a flow signal indicative of a flow of light scattering particles within the skin region, and an evaluation unit (36) for evaluating said PPG signal and said flow signal to obtain information on the peripheral arterial perfusion, wherein the evaluation unit is adapted to determine a state of low vascular compliance and / or a state of low cardiac output based on a combined evaluation of said PPG signal and said flow signal.
Owner:KONINKLIJKE PHILIPS NV

Systems and methods for determining systemic vascular resistance using bioimpedance

Methods, systems, and computer-readable medium for determining a systemic vascular resistance (SVR), by receiving a systolic blood pressure (SBP) and a diastolic blood pressure (DBP) from one or more blood pressure devices, receiving a first bioimpedance from a first electrode and a second bioimpedance from a second electrode, determining a stroke volume based on a difference between the first bioimpedance and the second bioimpedance, determining a mean arterial pressure (MAP) based on the SBP and the DBP, receiving a heart rate, determining a cardiac output based on the heart rate and the stroke volume, determining a first value based on a right atrial pressure (RAP) or central venous pressure (CVP) and the map, determining a second value based on the first value and the cardiac output, and determining a SVR based on the second value and a factor.
Owner:BAROPACE INC

Methods and devices for quantitative assessment of left ventricular outflow tract obstruction and aortic stenosis

This invention relates to a method and apparatus for quantitatively assessing left ventricular outflow tract obstruction and aortic stenosis. The method includes acquiring the outflow tract pressure gradient and cardiac output; determining the relationship between cardiac output and outflow tract pressure gradient using Bernoulli's equation; calculating the cardiac obstruction coefficient based on the equation; the cardiac obstruction coefficient includes the cardiac obstruction coefficient from the left ventricular cavity to the outflow tract segment and the cardiac obstruction coefficient from the outflow tract to the ascending aorta; and assessing the patient's obstruction status based on the cardiac obstruction coefficient. The cardiac obstruction coefficient calculated by this invention is mainly determined by the morphology of the patient's blood flow cavity and is not affected by cardiac output, thus providing a more accurate description of the patient's obstruction status. This helps physicians make more accurate clinical judgments.
Owner:BOYI HUIXIN (HANGZHOU) NETWORK TECH CO LTD

Systems and methods for determining systemic vascular resistance using photoplethysmography

Methods, systems, and computer-readable medium for determining a systemic vascular resistance (SVR), by receiving a systolic blood pressure (SBP) and a diastolic blood pressure (DPB) from a calibrated photoplethysmography (PPG) device, receiving a pulse transit time (PTT) from the PPG device, determining a stroke volume based on the PTT, determining a mean arterial pressure (MAP) based on the SBP and the DBP, receiving a heart rate, determining a cardiac output based on the heart rate and the stroke volume, determining a first value based on a right atrial pressure (RAP) or central venous pressure (CVP) and the map, determining a second value based on the first value and the cardiac output, and determining a SVR based on the second value and a factor.
Owner:BAROPACE INC

Self-adaptive driving method of total artificial heart

The invention relates to a self-adaptive driving method of a total artificial heart, which comprises the following steps: in a diastolic period, driving air to flow out of an air cavity of a TAH ventricle, closing an outflow valve of a blood cavity, opening an inflow valve of the blood cavity, enabling blood to enter the TAH ventricle, continuously discharging the air from the TAH ventricle, and entering a systolic period when partial volume of the TAH ventricle is still not filled with the blood; in the systolic period, the inflow valve for driving air to flow into the TAH ventricle air cavity and the blood cavity is closed, the outflow valve is opened, the diaphragm in the TAH ventricle expands upwards to eject the blood out of the TAH ventricle, and the blood in the TAH ventricle is completely ejected along with continuous entering of the compressed air and further rapid increase of the pressure. The full-artificial heart has the advantages that the driving concept of partial filling and complete ejection is adopted, under the condition that parameters of a driver are not adjusted, the cardiac output can adapt to fluctuation changes of the human body vein return blood volume in a self-adaptive mode, and the full-artificial heart has the driving effect of being self-adaptive to the human body.
Owner:XINXIN MEDICAL EQUIP (BEIJING) CO LTD